| Phase 14 trials |
|
Phase 1
|
NCT02375880 |
Jun 2015 → Jul 2018 |
cholangiocarcinoma, gallbladder carcinoma |
Leap Therapeutics, Inc. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT02013154 |
May 2014 → Jul 2019 |
gastric adenocarcinoma, gastroesophageal cancer, gastroesophageal junction adenocarcinoma, neoplasm of esophagus +1 |
Leap Therapeutics, Inc. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01711671 |
May 2013 → Jul 2015 |
plasma cell myeloma |
Leap Therapeutics, Inc. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01457417 |
Jan 2012 → Dec 2013 |
non-small cell lung carcinoma, plasma cell myeloma |
Leap Therapeutics, Inc. |
Completed
|
No outcome recorded
|
| Phase 1/23 trials |
|
Phase 1/2
|
NCT04166721 |
Feb 2020 → Mar 2025 overdue |
esophageal cancer, gastric cancer |
Royal Marsden NHS Foundation Trust |
Active not recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT03837353 |
Apr 2019 → Jul 2022 |
prostate cancer |
NYU Langone Health |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT03645980 |
Oct 2018 → Aug 2021 |
hepatocellular carcinoma |
Johannes Gutenberg University Mainz |
Unknown
|
No outcome recorded
|
| Phase 26 trials |
|
Phase 2
|
NCT05761951 |
Aug 2023 → Jan 2027 expected |
endometrial cancer |
M.D. Anderson Cancer Center |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05480306 |
Aug 2022 → Jul 2025 |
colorectal adenocarcinoma |
Leap Therapeutics, Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT04363801 |
Jul 2020 → Mar 2025 |
gastric adenocarcinoma, gastroesophageal cancer |
Leap Therapeutics, Inc. |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT03818997 |
Dec 2019 → Apr 2021 |
biliary tract cancer, esophageal cancer, gastroesophageal cancer |
European Organisation for Research and Treatment of Cancer - EORTC |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT04057365 |
Oct 2019 → Sep 2022 |
biliary tract cancer |
Massachusetts General Hospital |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT03395080 |
Mar 2018 → Sep 2020 |
carcinosarcoma, endometrial cancer, ovarian cancer |
Leap Therapeutics, Inc. |
Completed
|
No outcome recorded
|
| Phase not stated1 trial |
| — |
NCT04681248 |
— |
carcinosarcoma, endometrial cancer, gastric adenocarcinoma, gastroesophageal cancer +4 |
Leap Therapeutics, Inc. |
No longer available
|
No outcome recorded
|